Paper Details

  1. Home
  2. Paper Details

Association of cutaneous side-effects of hydroxyurea and neuroendocrine carcinoma.

Author: AvrilMarie-Françoise, BouldouyreMarie-Anne, GaulierAlain, Sigal-GrinbergMichèle

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a patient who developed a neuroendocrine carcinoma on the finger after long-term hydroxyurea (HU) therapy for thrombocytemia. The patient experienced cutaneous changes, including a dermatomyositis-like eruption and keratotic lesions, prior to the diagnosis of the carcinoma.
Paper Details　
Original Abstract of the Article :
Many cutaneous side-effects of long term use of hydroxyurea (HU) therapy are well known. We report the first case, to our knowledge, of a neuroendocrine carcinoma located on the finger associated with other cutaneous changes due to this drug. Our patient received HU for two years for an thrombocytem...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/16048756

データ提供：米国国立医学図書館（NLM）

Hydroxyurea and Neuroendocrine Carcinoma: A Potential Connection

The medical field is constantly seeking to understand the complex interactions between medications and various health conditions. This case report explores a potential link between hydroxyurea, a drug commonly used to treat certain blood disorders, and the development of neuroendocrine carcinoma. While the authors emphasize the need for further investigation, this report raises a critical question about the potential association between hydroxyurea and this type of cancer.

Hydroxyurea: A Potential Risk Factor for Neuroendocrine Carcinoma

The case report highlights the potential link between hydroxyurea and neuroendocrine carcinoma, suggesting that this drug might be a contributing factor in some cases. This is a crucial finding that underscores the importance of ongoing research and monitoring for potential adverse effects of medications.

A Reminder of Medication Safety

This case report serves as a reminder that even commonly used medications can have unexpected side effects. It emphasizes the need for careful monitoring, particularly for long-term use, and prompt reporting of any unusual symptoms. This study highlights the importance of continued research to better understand the complex interactions between medications and human health.

Dr. Camel's Conclusion

This research is a gentle reminder to always be vigilant about the potential side effects of medications. It's like traversing a vast desert – we must be aware of the hidden dangers that might lurk beneath the surface.

Date :
  1. Date Completed 2005-10-20
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

16048756

DOI: Digital Object Identifier

16048756

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.